View in EDS

ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.

Saved in:
Bibliographic Details
Title: ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.
Authors: Iland HJ; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Reynolds J; Biostatistics Consulting Platform, Monash University, Melbourne, Australia., Boddy AV; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia., Schultz HB; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia., Khoo L; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Fleming S; Department of Clinical Haematology, Alfred Hospital, Melbourne, Australia., Lane SW; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.; School of Medicine, University of Queensland, Brisbane, Australia., Weber N; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia., Gasiorowski R; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Haematology, Concord Hospital, Sydney, Australia., Armytage T; Haematology, Gosford Hospital, Gosford, Australia., Harrup R; Cancer and Blood Services, Royal Hobart Hospital, Hobart, Australia., Watson AM; Haematology, Liverpool Hospital, Sydney, Australia., Tan P; Haematology, Royal Perth Hospital, Perth, Australia., Filshie R; Haematology, St Vincent's Hospital, Melbourne, Australia., Kwok F; Haematology, Westmead Hospital, Sydney, Australia., Stevenson W; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Haematology, Royal North Shore Hospital, Sydney, Australia., Yuen S; Haematology, Calvary Mater Hospital, Newcastle, Australia., Ng AP; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia., Rowley L; Australasian Leukaemia and Lymphoma Group, Melbourne, Australia., Marlton P; School of Medicine, University of Queensland, Brisbane, Australia.; Haematology, Princess Alexandra Hospital, Brisbane, Australia., Wei AH; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.
Source: Blood advances [Blood Adv] 2025 Mar 25; Vol. 9 (6), pp. 1476-1484.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39874494
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Iland+HJ%22">Iland HJ</searchLink>; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Reynolds+J%22">Reynolds J</searchLink>; Biostatistics Consulting Platform, Monash University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Boddy+AV%22">Boddy AV</searchLink>; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Schultz+HB%22">Schultz HB</searchLink>; UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Khoo+L%22">Khoo L</searchLink>; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Fleming+S%22">Fleming S</searchLink>; Department of Clinical Haematology, Alfred Hospital, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Lane+SW%22">Lane SW</searchLink>; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.; School of Medicine, University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Weber+N%22">Weber N</searchLink>; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Gasiorowski+R%22">Gasiorowski R</searchLink>; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Haematology, Concord Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Armytage+T%22">Armytage T</searchLink>; Haematology, Gosford Hospital, Gosford, Australia.<br /><searchLink fieldCode="AU" term="%22Harrup+R%22">Harrup R</searchLink>; Cancer and Blood Services, Royal Hobart Hospital, Hobart, Australia.<br /><searchLink fieldCode="AU" term="%22Watson+AM%22">Watson AM</searchLink>; Haematology, Liverpool Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Tan+P%22">Tan P</searchLink>; Haematology, Royal Perth Hospital, Perth, Australia.<br /><searchLink fieldCode="AU" term="%22Filshie+R%22">Filshie R</searchLink>; Haematology, St Vincent's Hospital, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Kwok+F%22">Kwok F</searchLink>; Haematology, Westmead Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Stevenson+W%22">Stevenson W</searchLink>; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Haematology, Royal North Shore Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Yuen+S%22">Yuen S</searchLink>; Haematology, Calvary Mater Hospital, Newcastle, Australia.<br /><searchLink fieldCode="AU" term="%22Ng+AP%22">Ng AP</searchLink>; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Rowley+L%22">Rowley L</searchLink>; Australasian Leukaemia and Lymphoma Group, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Marlton+P%22">Marlton P</searchLink>; School of Medicine, University of Queensland, Brisbane, Australia.; Haematology, Princess Alexandra Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Wei+AH%22">Wei AH</searchLink>; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 Mar 25; Vol. 9 (6), pp. 1476-1484.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39874494
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2024015397
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1476
    Titles:
      – TitleFull: ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Iland HJ
      – PersonEntity:
          Name:
            NameFull: Reynolds J
      – PersonEntity:
          Name:
            NameFull: Boddy AV
      – PersonEntity:
          Name:
            NameFull: Schultz HB
      – PersonEntity:
          Name:
            NameFull: Khoo L
      – PersonEntity:
          Name:
            NameFull: Fleming S
      – PersonEntity:
          Name:
            NameFull: Lane SW
      – PersonEntity:
          Name:
            NameFull: Weber N
      – PersonEntity:
          Name:
            NameFull: Gasiorowski R
      – PersonEntity:
          Name:
            NameFull: Armytage T
      – PersonEntity:
          Name:
            NameFull: Harrup R
      – PersonEntity:
          Name:
            NameFull: Watson AM
      – PersonEntity:
          Name:
            NameFull: Tan P
      – PersonEntity:
          Name:
            NameFull: Filshie R
      – PersonEntity:
          Name:
            NameFull: Kwok F
      – PersonEntity:
          Name:
            NameFull: Stevenson W
      – PersonEntity:
          Name:
            NameFull: Yuen S
      – PersonEntity:
          Name:
            NameFull: Ng AP
      – PersonEntity:
          Name:
            NameFull: Rowley L
      – PersonEntity:
          Name:
            NameFull: Marlton P
      – PersonEntity:
          Name:
            NameFull: Wei AH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 03
              Text: 2025 Mar 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1